<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Isolated postchallenge <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (IPH), defined as fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (FPG) level &lt;7.0 mmol/l and 2-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (PG) level &gt;/=11.1 mmol/l, is a subtype of early-stage <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>This study evaluates the metabolic profiles of insulin secretion and insulin sensitivity in IPH to clarify the factors responsible for development of this form of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We conducted cross-sectional analysis of 231 Japanese men aged 20-70 years </plain></SENT>
<SENT sid="3" pm="."><plain>The subjects were classified into the following three groups, based on the results of a 75-g oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT): 1) <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT), defined as FPG level &lt;6.1 mmol/l and 2-h PG level &lt;7.8 mmol/l (n = 89); 2) <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT), defined as FPG level &lt;7.0 mmol/l and 2-h PG level of 7.8-11.1 mmol/l (n = 94); and 3) IPH (n = 48) </plain></SENT>
<SENT sid="4" pm="."><plain>We compared the three groups for insulin secretion (insulinogenic index) and insulin sensitivity (index of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> using homeostasis model assessment [HOMA-IR]) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The insulinogenic index in IPH was the lowest of the three groups (P &lt; 0.001 versus NGT) </plain></SENT>
<SENT sid="6" pm="."><plain>The HOMA-IR in the IGT and IPH groups were significantly higher than in the NGT group (P &lt; 0.001), but both were similar </plain></SENT>
<SENT sid="7" pm="."><plain>By linear regression analysis, the insulinogenic index rather than fasting insulin or HOMA-IR was the more significant factor in the 2-h PG level in IGT and IPH </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Subjects with IPH exhibited distinctly impaired early-phase insulin secretion and only mild <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, indicating that <z:mp ids='MP_0003059'>reduced insulin secretion</z:mp> is the primary determinant of deterioration from NGT to IGT and IPH in development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in these subjects </plain></SENT>
</text></document>